ResearcherVA Greater Los Angeles Healthcare SystemNo recent work listed
Ryan P. Merkow
Matched on ORCID iD 0000-0002-8752-4653; OpenAlex author ID A5011684815. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 5
- Evaluation of Adherence to Venous Thromboembolism Prophylaxis Guidelines Among US Adults After Pancreatic Cancer Surgery. Co-author DOI 10.1001/jamasurg.2022.2590↗
- National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection. Co-author DOI 10.1245/s10434-019-08023-1↗
- Does Second Reader Opinion Affect Patient Management in Pancreatic Ductal Adenocarcinoma? Co-author DOI 10.1016/j.acra.2017.12.010↗
- Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Co-author DOI 10.1097/sla.0000000000000378↗
- National assessment of margin status as a quality indicator after pancreatic cancer surgery. Co-author DOI 10.1245/s10434-013-3338-2↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David J. Bentrem · 3 shared papers, 2014–2020 · strength 0.22
- Paper National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resec… DOI 10.1245/s10434-019-08023-1↗
- Paper Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. DOI 10.1097/sla.0000000000000378↗
- Paper National assessment of margin status as a quality indicator after pancreatic cancer surgery. DOI 10.1245/s10434-013-3338-2↗
- Julie I. Hallet · 1 shared paper, 2022 · strength 0.17
- Sepideh Gholami · 1 shared paper, 2022 · strength 0.17
- Lauren M. Perry · 1 shared paper, 2022 · strength 0.17
- Robert J. Canter · 1 shared paper, 2022 · strength 0.17
- Sarah B. Bateni · 1 shared paper, 2022 · strength 0.17
- Richard J. Bold · 1 shared paper, 2022 · strength 0.17
- Anthony D. Yang · 1 shared paper, 2020 · strength 0.13
- Ryan J. Ellis · 1 shared paper, 2020 · strength 0.13
- Vinod P. Balachandran · 1 shared paper, 2018 · strength 0.08
- Lorenzo Mannelli · 1 shared paper, 2018 · strength 0.08
- Giuseppe Corrias · 1 shared paper, 2018 · strength 0.08
- Sandra Huicochea Castellanos · 1 shared paper, 2018 · strength 0.08
- Marina Talamonti · 1 shared paper, 2014 · strength 0.04
- Henry Anthony Pitt · 1 shared paper, 2014 · strength 0.04
- Mitchell C. Posner · 1 shared paper, 2014 · strength 0.04
- Jason B. Fleming · 1 shared paper, 2014 · strength 0.04
- Timothy Michael Pawlik · 1 shared paper, 2014 · strength 0.04
- James S. Tomlinson · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.